Posted in:Legal The Continuing Evolution of Obviousness Type Double Patenting By Monica Chin Kitts December 21, 2018 Comments are off Prior to 1994, the term of a U.S. patent was 17 years from the date of issuance. When the Uruguay Round Agreements Act (“URAA”)... Read more Tagged with: AbbVie, Breckenridge Pharmaceutical, Federal Circuit, Gilead Sciences, Natco Pharma, Novartis AG http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus